Brafield Investments Limited 28/02/2021 iXBRL
Brafield Investments Limited 28/02/2021 iXBRL
Company registration number:
10613899
Statement of financial position
28 February 2021
2021 | 2020 | ||||||||
Note | £ | £ | £ | £ | |||||
Current assets | |||||||||
Cash at bank and in hand |
|
|
|||||||
_______ | _______ | ||||||||
Net current assets |
|
|
|||||||
_______ | _______ | ||||||||
Net assets |
|
|
|||||||
_______ | _______ | ||||||||
Capital and reserves | |||||||||
Called up share capital |
|
|
|||||||
_______ | _______ | ||||||||
Shareholder funds |
|
|
|||||||
_______ | _______ | ||||||||
Director's responsibilities:
-
The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
-
The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the
board of directors
and authorised for issue on
02 August 2021
, and are signed on behalf of the board by:
Director
Company registration number:
10613899
Notes to the financial statements
Year ended 28 February 2021
1.
General information
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is 35 Colworth House, Colworth Park, Sharnbrook, Bedford, MK44 1LQ.
2.
Statement of compliance
3.
Accounting policies
Basis of preparation
Going concern
Taxation
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Debt instruments are subsequently measured at amortised cost.
For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics.
Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.